AUSTIN, Texas, May 19, 2014 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTCQB:BICX), a leader in addiction treatment programs, is now available. The interview can be heard at http://smallcapvoice.com/blog/5-16-14-smallcapvoice-interview-with-biocorrx-inc-bicx
BioCorRx, Inc. announced its financial results for the 3 months ending March 31, 2014. The full 10-Q filing is available on the SEC's website at http://edgar.sec.gov/
"By focusing on branding and expansion to reach mass market adoption, BioCorRx Inc. will continue to position its Start Fresh Program as a leader in treating alcohol and opioid addiction," stated Lourdes Felix.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About BioCorRx, Inc.
BioCorRx, Inc. (OTCQB:BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh ProgramTM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. For more information on BICX, visit www.BioCorRx.com.
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
Investor Relations: SmallCapVoice.com, Inc. 512-267-2430